Related Experiment Video
Updated: Sep 11, 2025

Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Opioid-containing antitussives in Switzerland: a descriptive cross-sectional time-series analysis of pharmacy sales
Lucia Gasparovic1, Dominik Stämpfli1, Shanzeh Chaudhry2
1Institute of Pharmaceutical Sciences, Department of Chemistry and Applied Biosciences, ETH Zurich, Zurich, Switzerland.
Background:
Opioid-containing antitussives are used to symptomatically treat a dry, irritative cough but bring a risk of misuse as recreational drugs. Since the update of the Swiss Therapeutic Products Act in 2019, opioid-containing antitussives are regulated more strictly, being available only on prescription and no longer over the counter.
Aim:
This study aimed to describe the sales trends of opioid-containing antitussives in Switzerland between 2011 and 2022 to assess the impact of the regulation change.
Methods:
We descriptively analysed cross-sectional data of opioid sales from wholesalers to pharmacies and self-dispensing physicians as an indicator of community use.
Main Findings:
An estimated 369 million standard units of opioid-containing antitussives were sold over the whole observation period, of which 59% contained dextromethorphan as the active ingredient. Sales decreased slowly between 2011 and 2019, then dropped substantially in 2020 (-30.4% compared to previous year) and 2021 (-15.2%), then partially recovered in 2022. The sales of codeine-containing antitussives did not recover until the end of the study period (quarter 3 of 2022) and remained 37.3% lower than before the rescheduling (quarter 4 of 2018).
Discussion:
It is likely that repeated media attention on cases of misuse of opioid-containing antitussives led to more cautious dispensing in Switzerland leading up to the revision of the Therapeutic Products Act in 2019. The substantial decrease in sales in 2020 and 2021 was likely related to the COVID-19 pandemic rather than the rescheduling of opioid-containing antitussives. Longer data collection will be needed to assess the impact of the regulation change post-pandemic.
More Related Videos
Related Concept Videos
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Opioid Analgesics: Morphine and Other Natural Cogeners
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Classes and Categories
Analgesia and Pain Management

